About BHR Pharma
BHR Pharma, LLC (BHR), a Besins Healthcare Company, is a pharmaceutical research & development company committed to developing therapeutic products using non-oral delivery systems for patient populations with unmet and underserved medical needs.
BHR Pharma Fact Sheets
- BHR Overview (pdf)
- SyNAPSe (pdf)
BHR Pharma Press Releases
- March 21, 2012
BHR Pharma's SyNAPSe® Trial Reaches Important Enrollment Milestone on Brain Injury Awareness Day - September 7, 2011
BHR Pharma Meets Critical Enrollment Milestone for its SyNAPSe® Clinical Trial - March 7, 2011
BHR Pharma Sponsors 2011 Brain Injury Awareness Day - July 23, 2010
BHR Pharma Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial - Mar. 23, 2010
BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now - Dec. 8, 2009
BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment (pdf) - Sept. 8, 2009
BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury (pdf)
Contact Us
607 Herndon Parkway, Suite 110
Herndon, VA 20170
Phone: 703-964-3033
Fax: 703-964-3044
Email:
